Channing Capital Management LLC lessened its holdings in shares of National Vision Holdings, Inc. (NASDAQ:EYE – Free Report) by 28.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 234,115 shares of the company’s stock after selling 91,543 shares during the period. Channing Capital Management LLC owned approximately 0.30% of National Vision worth $6,834,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in National Vision by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company’s stock valued at $591,000 after buying an additional 1,948 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in National Vision by 6.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company’s stock valued at $3,005,000 after acquiring an additional 13,384 shares in the last quarter. CWM LLC boosted its stake in National Vision by 7.4% in the 2nd quarter. CWM LLC now owns 12,350 shares of the company’s stock worth $284,000 after purchasing an additional 856 shares during the period. Linden Thomas Advisory Services LLC increased its holdings in National Vision by 45.1% during the 2nd quarter. Linden Thomas Advisory Services LLC now owns 47,343 shares of the company’s stock worth $1,089,000 after purchasing an additional 14,721 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of National Vision in the 2nd quarter valued at about $203,000.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on EYE. Guggenheim raised National Vision to a “strong-buy” rating in a research report on Wednesday, December 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of National Vision in a research report on Thursday, January 22nd. Citigroup lifted their price objective on shares of National Vision from $29.00 to $35.00 and gave the company a “buy” rating in a report on Tuesday, November 18th. Morgan Stanley boosted their price objective on shares of National Vision from $26.00 to $30.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 15th. Finally, Zacks Research raised shares of National Vision from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.00.
National Vision Stock Up 0.6%
NASDAQ:EYE opened at $27.35 on Friday. National Vision Holdings, Inc. has a twelve month low of $10.45 and a twelve month high of $30.02. The firm has a market capitalization of $2.17 billion, a price-to-earnings ratio of -911.36, a price-to-earnings-growth ratio of 1.56 and a beta of 1.39. The company has a quick ratio of 0.32, a current ratio of 0.53 and a debt-to-equity ratio of 0.28. The stock’s 50 day moving average price is $27.47 and its two-hundred day moving average price is $26.33.
About National Vision
National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.
Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.
See Also
- Five stocks we like better than National Vision
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold $5,000: The 2026 Gold & Silver Summit is LIVE March 4
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Want to see what other hedge funds are holding EYE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Vision Holdings, Inc. (NASDAQ:EYE – Free Report).
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
